Search Results - Claus Garbe

Refine Results
  1. 1

    Diagnostic Performance of a Support Vector Machine for Dermatofluoroscopic Melanoma Recognition: The Results of the Retrospective Clinical Study on 214 Pigmented Skin Lesions by Łukasz Szyc, Uwe Hillen, Constantin Scharlach, Friederike Kauer, Claus Garbe

    Published in Diagnostics (2019-08-01)
    Get full text
    Article


  2. 2

    Embryonic bone morphogenetic protein and nodal induce invasion in melanocytes and melanoma cells by Tobias Sinnberg, Heike Niessner, Mitchell P. Levesque, Christoph Dettweiler, Claus Garbe, Christian Busch

    Published in Biology Open (2018-06-01)
    Get full text
    Article


  3. 3

    Distress and Its Determinants in 820 Consecutive Melanoma Patients by Markus Reitmajer, Petra Riedel, Claus Garbe, Norbert Schäffeler, Thomas K. Eigentler, Andrea Forschner

    Published in Cancer Medicine (2025-03-01)
    Get full text
    Article


  4. 4

    A novel role for relaxin-2 in the pathogenesis of primary varicosis. by Julia Adams, Sarah Schott, Arno Bern, Matthias Renz, Kristian Ikenberg, Claus Garbe, Christian Busch

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  5. 5

    β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance. by Tobias Sinnberg, Moritz Menzel, Daniel Ewerth, Birgit Sauer, Michael Schwarz, Martin Schaller, Claus Garbe, Birgit Schittek

    Published in PLoS ONE (2011-01-01)
    Get full text
    Article


  6. 6

    BRAF-V600 mutations have no prognostic impact in stage IV melanoma patients treated with monochemotherapy. by Diana Meckbach, Ulrike Keim, Sabina Richter, Ulrike Leiter, Thomas K Eigentler, Jürgen Bauer, Annette Pflugfelder, Petra Büttner, Claus Garbe, Benjamin Weide

    Published in PLoS ONE (2014-01-01)
    Get full text
    Article


  7. 7

    Melanoma patients with unknown primary site or nodal recurrence after initial diagnosis have a favourable survival compared to those with synchronous lymph node metastasis and prim... by Benjamin Weide, Christine Faller, Margrit Elsässer, Petra Büttner, Annette Pflugfelder, Ulrike Leiter, Thomas Kurt Eigentler, Jürgen Bauer, Friedegund Meier, Claus Garbe

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  8. 8

    Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy. by Benjamin Weide, Sabina Richter, Petra Büttner, Ulrike Leiter, Andrea Forschner, Jürgen Bauer, Laura Held, Thomas Kurt Eigentler, Friedegund Meier, Claus Garbe

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  9. 9

    Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype by Tobias Sinnberg, Mitchell P. Levesque, Jelena Krochmann, Phil F. Cheng, Kristian Ikenberg, Francisco Meraz-Torres, Heike Niessner, Claus Garbe, Christian Busch

    Published in Molecular Cancer (2018-02-01)
    Get full text
    Article


  10. 10

    Modifiable Risk-factors for Keratinocyte Cancers in Australia: A Case-control Study by Lina Maria Serna-Higuita, Simone L. Harrison, Petra Buttner, Margaret Glasby, Beverly A. Raasch, Angelika Iftner, Claus Garbe, Peter Martus, Thomas Iftner

    Published in Acta Dermato-Venereologica (2019-02-01)
    Get full text
    Article


  11. 11

    Is there a link between very early changes of primary and secondary lymphoid organs in 18F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy? by Konstantin Nikolaou, Andrea Forschner, Benjamin Weide, Claus Garbe, Christina Pfannenberg, Ahmed E Othman, Johannes Schwenck, Christian la Fougère, Ferdinand Seith, Brigitte Gückel, Martin Schwartz, Matthias Fenchel, Nina Schwenzer

    Published in Journal for ImmunoTherapy of Cancer (2020-10-01)
    Get full text
    Article


  12. 12

    Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy by Francisco Meraz-Torres, Heike Niessner, Sarah Plöger, Simon Riel, Barbara Schörg, Nicolas Casadei, Manfred Kneilling, Martin Schaller, Lukas Flatz, Boris Macek, Thomas Eigentler, Olaf Rieß, Claus Garbe, Teresa Amaral, Tobias Sinnberg

    Get full text
    Article


  13. 13

    Adjuvant anti-PD-1 therapy improves melanoma-specific survival in stage IIIC-IV melanoma patients with high tumor mutation burden and BRAF V600 mutation by Julia Forschner, Julia Huynh, Christopher Schroeder, Sorin Armeanu-Ebinger, Olga Seibel-Kelemen, Axel Gschwind, Irina Bonzheim, Thomas K. Eigentler, Teresa Amaral, Stephan Ossowski, Lukas Flatz, Claus Garbe, Andrea Forschner, Markus Reitmajer

    Published in Frontiers in Oncology (2025-08-01)
    Get full text
    Article


  14. 14

    Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma by Teresa Amaral, Benjamin Weide, Graham Pawelec, Thomas Eigentler, Claus Garbe, Patrick Terheyden, Friedegund Meier, Kilian Wistuba-Hamprecht, Alexander Martens, Jonas Bochem, Janine Spreuer, Andrea Gaissler, Shannon Ottmann, Nikolaus Benjamin Wagner, Manfred Claassen

    Published in Journal for ImmunoTherapy of Cancer (2023-06-01)
    Get full text
    Article


  15. 15

    Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition by Christopher Schroeder, Sergios Gatidis, Olga Kelemen, Leon Schütz, Irina Bonzheim, Francesc Muyas, Peter Martus, Jakob Admard, Sorin Armeanu-Ebinger, Brigitte Gückel, Thomas Küstner, Claus Garbe, Lukas Flatz, Christina Pfannenberg, Stephan Ossowski, Andrea Forschner

    Published in Nature Communications (2024-10-01)
    Get full text
    Article


  16. 16

    Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II tria... by Celeste Lebbe, Parminder Singh, Omid Hamid, Frances A Collichio, Igor Puzanov, Merrick Ross, Theodore Logan, Philip Friedlander, Claus Garbe, Janice M Mehnert, John Glaspy, Axel Hauschild, Wendy Snyder, Jason A Chesney, Mohammed M Milhem, Harshada Joshi

    Published in Journal for ImmunoTherapy of Cancer (2023-05-01)
    Get full text
    Article


  17. 17

    Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma – results of a prospective biomarker study by Andrea Forschner, Florian Battke, Dirk Hadaschik, Martin Schulze, Stephanie Weißgraeber, Chung-Ting Han, Maria Kopp, Maximilian Frick, Bernhard Klumpp, Nicola Tietze, Teresa Amaral, Peter Martus, Tobias Sinnberg, Thomas Eigentler, Ulrike Keim, Claus Garbe, Dennis Döcker, Saskia Biskup

    Published in Journal for ImmunoTherapy of Cancer (2019-07-01)
    Get full text
    Article


  18. 18

    Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies by Nikolaus B. Wagner, Benjamin Weide, Mirko Gries, Maike Reith, Kathrin Tarnanidis, Valerie Schuermans, Charlotte Kemper, Coretta Kehrel, Anne Funder, Ramtin Lichtenberger, Antje Sucker, Esther Herpel, Tim Holland-Letz, Dirk Schadendorf, Claus Garbe, Viktor Umansky, Jochen Utikal, Christoffer Gebhardt

    Published in Journal for ImmunoTherapy of Cancer (2019-12-01)
    Get full text
    Article


  19. 19

    The “Great Debate” at Melanoma Bridge 2022, Naples, December 1st–3rd, 2022 by Paolo A. Ascierto, Christian Blank, Alexander M. Eggermont, Claus Garbe, Jeffrey E. Gershenwald, Omid Hamid, Axel Hauschild, Jason J. Luke, Janice M. Mehnert, Jeffrey A. Sosman, Hussein A. Tawbi, Mario Mandalà, Alessandro Testori, Corrado Caracò, Iman Osman, Igor Puzanov

    Published in Journal of Translational Medicine (2023-04-01)
    Get full text
    Article


  20. 20

    Deep learning-based scoring of tumour-infiltrating lymphocytes is prognostic in primary melanoma and predictive to PD-1 checkpoint inhibition in melanoma metastasesResearch in cont... by Eftychia Chatziioannou, Jana Roßner, Thazin New Aung, David L. Rimm, Heike Niessner, Ulrike Keim, Lina Maria Serna-Higuita, Irina Bonzheim, Luis Kuhn Cuellar, Dana Westphal, Julian Steininger, Friedegund Meier, Oltin Tiberiu Pop, Stephan Forchhammer, Lukas Flatz, Thomas Eigentler, Claus Garbe, Martin Röcken, Teresa Amaral, Tobias Sinnberg

    Published in EBioMedicine (2023-07-01)
    Get full text
    Article


Search Tools: